Article
<i>In vivo</i> CRISPR screens reveal SCAF1 and USP15 as novel drivers of pancreatic cancer
2022-03-13
Abstract excerpt
Functionally characterizing the genetic alterations that drive pancreatic cancer progression is a prerequisite for Precision Medicine. Here, we developed a somatic CRISPR/Cas9 mutagenesis screen to assess the transforming potential of 125 recurrently mutated ‘long-tail’ pancreatic cancer genes, which revealed USP15 and SCAF1 as novel and potent Pancreatic ductal adenocarcinoma PDAC tumor suppressors, with USP15 fu...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- c14ece73-3e2e-5118-9b52-f8c40f98795f
- DOI
- 10.1101/2022.03.13.484174
